HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.

Abstract
Here, we show that new mitochondrial biogenesis is required for the anchorage independent survival and propagation of cancer stem-like cells (CSCs). More specifically, we used the drug XCT790 as an investigational tool, as it functions as a specific inhibitor of the ERRα-PGC1 signaling pathway, which governs mitochondrial biogenesis. Interestingly, our results directly demonstrate that XCT790 efficiently blocks both the survival and propagation of tumor initiating stem-like cells (TICs), using the MCF7 cell line as a model system. Mechanistically, we show that XCT790 suppresses the activity of several independent signaling pathways that are normally required for the survival of CSCs, such as Sonic hedgehog, TGFβ-SMAD, STAT3, and Wnt signaling. We also show that XCT790 markedly reduces oxidative mitochondrial metabolism (OXPHOS) and that XCT790-mediated inhibition of CSC propagation can be prevented or reversed by Acetyl-L-Carnitine (ALCAR), a mitochondrial fuel. Consistent with our findings, over-expression of ERRα significantly enhances the efficiency of mammosphere formation, which can be blocked by treatment with mitochondrial inhibitors. Similarly, mammosphere formation augmented by FOXM1, a downstream target of Wnt/β-catenin signaling, can also be blocked by treatment with three different classes of mitochondrial inhibitors (XCT790, oligomycin A, or doxycycline). In this context, our unbiased proteomics analysis reveals that FOXM1 drives the expression of >90 protein targets associated with mitochondrial biogenesis, glycolysis, the EMT and protein synthesis in MCF7 cells, processes which are characteristic of an anabolic CSC phenotype. Finally, doxycycline is an FDA-approved antibiotic, which is very well-tolerated in patients. As such, doxycycline could be re-purposed clinically as a 'safe' mitochondrial inhibitor, to target FOXM1 and mitochondrial biogenesis in CSCs, to prevent tumor recurrence and distant metastasis, thereby avoiding patient relapse.
AuthorsArianna De Luca, Marco Fiorillo, Maria Peiris-Pagès, Bela Ozsvari, Duncan L Smith, Rosa Sanchez-Alvarez, Ubaldo E Martinez-Outschoorn, Anna Rita Cappello, Vincenzo Pezzi, Michael P Lisanti, Federica Sotgia
JournalOncotarget (Oncotarget) Vol. 6 Issue 17 Pg. 14777-95 (Jun 20 2015) ISSN: 1949-2553 [Electronic] United States
PMID26087310 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ERRalpha estrogen-related receptor
  • FOXM1 protein, human
  • Forkhead Box Protein M1
  • Forkhead Transcription Factors
  • Nitriles
  • Oligomycins
  • Receptors, Estrogen
  • Thiazoles
  • XCT790
  • Acetylcarnitine
  • Doxycycline
Topics
  • Acetylcarnitine (pharmacology)
  • Breast Neoplasms (genetics, metabolism, pathology)
  • Cell Adhesion (drug effects, physiology)
  • Cell Proliferation (drug effects, physiology)
  • Cell Survival (drug effects, physiology)
  • Chromatography, Liquid
  • Doxycycline (pharmacology)
  • Forkhead Box Protein M1
  • Forkhead Transcription Factors (genetics, metabolism)
  • Glycolysis (drug effects)
  • Humans
  • MCF-7 Cells
  • Mitochondria (drug effects, metabolism)
  • Neoplastic Stem Cells (drug effects, metabolism)
  • Nitriles (pharmacology)
  • Oligomycins (pharmacology)
  • Organelle Biogenesis
  • Oxidative Phosphorylation (drug effects)
  • Proteomics (methods)
  • Receptors, Estrogen (genetics, metabolism)
  • Signal Transduction (drug effects)
  • Spheroids, Cellular (drug effects, metabolism)
  • Tandem Mass Spectrometry
  • Thiazoles (pharmacology)
  • Wnt Signaling Pathway (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: